Aryanian Zeinab, Balighi Kamran, Azizpour Arghavan, Kamyab Hesari Kambiz, Hatami Parvaneh
Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Department of Dermatology, Babol University of Medical Sciences, Babol, Iran.
Case Rep Dermatol Med. 2022 Aug 28;2022:2324212. doi: 10.1155/2022/2324212. eCollection 2022.
SARS-CoV-2 vaccines were approved without long-term monitoring due to emergent situation and might have several side effects. Herein, we describe the first case with development of both LP and PV following COVID-19 vaccination. Immunological alteration due to COVID-19 vaccination and its potential role in triggering autoimmune disorders were also dealt with.
由于紧急情况,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗未经长期监测就获得了批准,可能会有多种副作用。在此,我们描述了首例接种2019冠状病毒病(COVID-19)疫苗后发生大疱性类天疱疮(LP)和寻常型天疱疮(PV)的病例。还探讨了COVID-19疫苗接种引起的免疫改变及其在引发自身免疫性疾病中的潜在作用。